Saturday, 27 April 2024
Catalyst Pharmaceutical Partners Inc.
-
Overlay
-
Indicators
-
Settings
-
Period
05:12 | 8/3/18
Wallstreet Investorplace
Catalyst Pharmaceuticals, Inc. (CPRX) stock price performed at a change of 0.30% from 20 day SMA and stands at a distance of -8.20% away from 50 day SMA.
more»
04:28 | 8/3/18
The Ledger Gazette
Catalyst Pharmaceuticals logo Bogle Investment Management L P DE acquired a new position in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange ...
more»
11:18 | 7/3/18
Frisco Fastball
Alliancebernstein Lp reported 0% in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Tower Cap Ltd Llc (Trc) stated it has 15,261 shares.
more»
11:52 | 6/3/18
Frisco Fastball
Principal Financial Group Inc reported 11,220 shares. Goldman Sachs Inc holds 0% of its portfolio in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) for 45,568 shares. Voya Invest Limited Liability Corp, Georgia-based fund reported 32,973 shares. Jpmorgan ...
more»
04:00 | 6/3/18
Alpha Beta Stock
U.S. stocks closed well off session lows on Friday, assisted by a sharp rise in health care shares. The S&P 500 ended 0.5 percent higher at 2,691.25 after falling more than 1 percent.
more»
03:27 | 6/3/18
Stocks Gallery
Shares of Catalyst Pharmaceuticals, Inc. (CPRX) moved 0.00% in the recent trading day. Last trading transaction put the stock price at $3.20.
more»
07:45 | 3/3/18
The Ledger Gazette
Catalyst Pharmaceuticals logo Wall Street brokerages predict that Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) will announce earnings of ($0.06) per share for the current fiscal quarter, Zacks Investment Research reports.
more»
03:15 | 3/3/18
Key Gazette
Among 5 analysts covering Catalyst Pharmaceuticals (NASDAQ:CPRX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive.
more»
03:13 | 3/3/18
Stocks Gallery
In recent trading day Catalyst Pharmaceuticals, Inc. (CPRX) stock showed the move of 0.31% with the closing price of $3.20.
more»
02:41 | 2/3/18
Frisco Fastball
Schwab Charles Investment Mgmt Inc has invested 0% in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Hbk Sorce Advisory Ltd Co stated it has 21,109 shares or 0.01% of all its holdings.
more»